The male group had significantly higher rates of hypertension (54.1% vs. 16.7%, p = 0.043) and renin-angiotensin system inhibitor (RASi) use (32.4% vs. 0%, p = 0.024) than the female group. This evidence concerns the gene REN and Hypertension.